Health / Medical Topics

    Linaclotide

    A synthetic, fourteen amino acid peptide and agonist of intestinal guanylate cyclase type C (GC-C), which is structurally related to the guanylin peptide family, with secretagogue, analgesic and laxative activities. Upon oral administration, linaclotide binds to and activates GC-C receptors located on the luminal surface of the intestinal epithelium. This increases the concentration of intracellular cyclic guanosine monophosphate (cGMP), which is derived from guanosine triphosphate (GTP). cGMP activates the cystic fibrosis transmembrane conductance regulator (CFTR) and stimulates the secretion of chloride and bicarbonate into the intestinal lumen. This promotes sodium excretion into the lumen and results in increased intestinal fluid secretion. This ultimately accelerates GI transit of intestinal contents, improves bowel movement and relieves constipation. Increased extracellular cGMP levels may also exert an antinociceptive effect, through an as of yet not fully elucidated mechanism, that may involve modulation of nociceptors found on colonic afferent pain fibers. Linaclotide is minimally absorbed from the GI tract. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    A machine that uses electricity to form a stream of fast-moving subatomic particles. This creates high-energy radiation that may be used to…
    Human LIN28B wild-type allele is located in the vicinity of 6q21 and is approximately 126 kb in length. This allele, which encodes…
    This gene plays a role in the suppression of miRNA processing.
    Human LIN28 wild-type allele is located in the vicinity of 1p36.11 and is approximately 19 kb in length. This allele, which encodes…
    This gene is involved in the enhancement of translation.
    Lin-28 homolog A (209 aa, ~23 kDa) is encoded by the human LIN28 gene. This protein is involved in enhancing translation. …

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact